We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

27 hedge funds and large institutions have $468K invested in Trinity Biotech in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

17% more funds holding

Funds holding: 23 → 27 (+4)

0.5% less ownership

Funds ownership: 0.72% → 0.23% (-0.5%)

80% less capital invested

Capital invested by funds: $2.3M → $468K (-$1.83M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 8

Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
8
Closed
4
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$52.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$32.8K
3
WN
Williams & Novak
California
+$14.4K
4
TSS
Two Sigma Securities
New York
+$13.8K
5
Two Sigma Investments
Two Sigma Investments
New York
+$11.9K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$1.58M
2
Renaissance Technologies
Renaissance Technologies
New York
-$88.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K
4
GI
GAMMA Investing
California
-$9.98K
5
UBS Group
UBS Group
Switzerland
-$9.35K
Name Holding Trade Value Shares
Change 		Change in
Stake
HAIM
1
Hunter Associates Investment Management
Pennsylvania
$214K -$2.75K -3,480 -0.9%
WCM
2
Whitefort Capital Management
New York
$46.7K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$43.7K -$88.7K -112,388 -59%
HF
4
HRT Financial
New York
$37K +$52.3K +66,242 New
Citadel Advisors
5
Citadel Advisors
Florida
$23.7K +$32.8K +41,539 New
MAWA
6
Moss Adams Wealth Advisors
Washington
$14.6K – – –
Raymond James Financial
7
Raymond James Financial
Florida
$14.5K -$780 -988 -4%
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$13K – – –
WN
9
Williams & Novak
California
$10.4K +$14.4K +18,200 New
BCM
10
Becker Capital Management
Oregon
$10.3K – – –
TSS
11
Two Sigma Securities
New York
$10K +$13.8K +17,547 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$9.48K -$815 -1,033 -6%
Two Sigma Investments
13
Two Sigma Investments
New York
$8.59K +$11.9K +15,073 New
IWA
14
Inspirion Wealth Advisors
Illinois
$5.7K – – –
Osaic Holdings
15
Osaic Holdings
Arizona
$2.56K +$3.55K +4,500 New
Morgan Stanley
16
Morgan Stanley
New York
$1.23K – – –
FFA
17
Farther Finance Advisors
California
$1.14K +$1.58K +2,000 New
RhumbLine Advisers
18
RhumbLine Advisers
Massachusetts
$746 -$391 -496 -27%
GI
19
GAMMA Investing
California
$367 -$9.98K -12,646 -95%
Jones Financial Companies
20
Jones Financial Companies
Missouri
$300 – – –
CIBC Private Wealth Group
21
CIBC Private Wealth Group
Georgia
$115 – – –
Bank of America
22
Bank of America
North Carolina
$23 -$158 -200 -83%
AP
23
Atwood & Palmer
Missouri
$12 – – –
SS
24
SBI Securities
Japan
$6 +$8 +10 New
NA
25
NewEdge Advisors
Louisiana
$3 – – –
1
2

TRIB Hedge Fund Activity: Q1 2025 in Review

27 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2025, worth a combined $468K — down 80% from $2.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TRIB positions and 4 closed out — a net gain of 4 holders — while 0 added to existing stakes and 8 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $52.3K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.58M sold.

  • 27 institutional investors held Trinity Biotech (TRIB) as of Q1 2025, up from 23 in Q4 2024.
  • Funds reported $468K of Trinity Biotech stock for Q1 2025, down 80% quarter-over-quarter.
  • 8 funds opened new Trinity Biotech positions in Q1 2025 and 4 closed out, a net change of +4 holders.
  • The largest Trinity Biotech buyer in Q1 2025 was HRT Financial, an estimated $52.3K added.
  • The largest Trinity Biotech seller in Q1 2025 was Perceptive Advisors, an estimated $1.58M sold.

Based on aggregated 13F filings for Q1 2025.